CN Patent

CN104619316B — 用于降低n-氧化三甲胺水平的药物组合物

Assigned to Latvian Institute of Organic Synthesis · Expires 2018-04-27 · 8y expired

What this patent protects

本发明公开了用于体内N‑氧化三甲胺水平下降的含3‑(2,2,2‑三甲基肼)丙酸盐、其二水合物或其药物学上可接受的盐的药物组合物的应用。

USPTO Abstract

本发明公开了用于体内N‑氧化三甲胺水平下降的含3‑(2,2,2‑三甲基肼)丙酸盐、其二水合物或其药物学上可接受的盐的药物组合物的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN104619316B
Jurisdiction
CN
Classification
—
Expires
2018-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Latvian Institute of Organic Synthesis
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.